An AstraZeneca Plc executive
said the British drugmaker would consider not submitting its
COVID-19 vaccine for approval in the United States if the
regulatory process takes too long, the Financial. | March 17, 2022
(Reuters) -Biogen Inc said on Wednesday patients in a long-term trial of its Alzheimer's drug Aduhelm experienced reductions in two key disease indica.
(Reuters) -A growing number of drugmakers including Eli Lilly and Co, Novartis and Abbvie Inc are scaling back business in Russia after Moscow's invasion
(Reuters) -U.S. drugmaker Eli Lilly and Co said on Tuesday it would continue to supply drugs to Russia for urgent medical conditions such as cancer and